VCEL FY 2018 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$91M+42.1% YoY

Gross Profit

$59M64.6% margin

Operating Income

-$4M-4.3% margin

Net Income

-$8M-9.0% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

-$412,000

Free Cash Flow

-$3M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$119M

Total Liabilities

$16M

Stockholders' Equity

$102M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$64M	+42.1%
Gross Profit	$59M	$34M	+74.8%
Operating Income	-$4M	-$15M	+73.9%
Net Income	-$8M	-$17M	+52.9%